Simultaneous BRCA1 and PALB2 pathogenic variants in a patient with triple-negative breast cancer
Introduction: Triple-negative breast cancer (TNBC) accounts for approximately 15% of breast cancers. BRCA1 mutations occur in up to 20% of TNBC cases; simultaneous pathogenic variants in BRCA1 and PALB2 in a single patient are exceedingly rare, with poorly characterized combined clinical implications. Case report: A 5...